Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Management of epilepsy in brain tumors.

Maschio M, Aguglia U, Avanzini G, Banfi P, Buttinelli C, Capovilla G, Casazza MML, Colicchio G, Coppola A, Costa C, Dainese F, Daniele O, De Simone R, Eoli M, Gasparini S, Giallonardo AT, La Neve A, Maialetti A, Mecarelli O, Melis M, Michelucci R, Paladin F, Pauletto G, Piccioli M, Quadri S, Ranzato F, Rossi R, Salmaggi A, Terenzi R, Tisei P, Villani F, Vitali P, Vivalda LC, Zaccara G, Zarabla A, Beghi E; Brain Tumor-related Epilepsy study group of Italian League Against Epilepsy (LICE).

Neurol Sci. 2019 Oct;40(10):2217-2234. doi: 10.1007/s10072-019-04025-9. Epub 2019 Aug 7.

PMID:
31392641
2.

Comorbidity between epilepsy and cardiac arrhythmias: Implication for treatment.

Zaccara G, Lattanzi S.

Epilepsy Behav. 2019 Aug;97:304-312. doi: 10.1016/j.yebeh.2019.05.038. Epub 2019 Jul 3. Review.

PMID:
31279643
3.

Incidence, management and short-term prognosis of status epilepticus in the emergency department: a population survey.

Nazerian P, Lazzeretti D, Vanni S, Donnarumma E, Magazzini S, Ruggiano G, Giannasi G, Grifoni S, Zaccara G.

Eur J Emerg Med. 2019 Jun;26(3):228-230. doi: 10.1097/MEJ.0000000000000568. No abstract available.

PMID:
31033621
4.

Validated outcome of treatment changes according to International League Against Epilepsy criteria in adults with drug-resistant focal epilepsy.

Mula M, Zaccara G, Galimberti CA, Ferrò B, Canevini MP, Mascia A, Mecarelli O, Michelucci R, Pisani LR, Specchio LM, Striano S, Perucca E.

Epilepsia. 2019 Jun;60(6):1114-1123. doi: 10.1111/epi.14685. Epub 2019 Mar 13.

5.

Do neurologists agree in diagnosing drug resistance in adults with focal epilepsy?

Zaccara G, Mula M, Ferrò B, Consoli D, Elia M, Giallonardo AT, Iudice A, La Neve A, Meletti S, Tinuper P, Zummo L, Perucca E.

Epilepsia. 2019 Jan;60(1):175-183. doi: 10.1111/epi.14622. Epub 2018 Dec 25.

PMID:
30585315
6.

Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.

Lattanzi S, Brigo F, Trinka E, Zaccara G, Cagnetti C, Del Giovane C, Silvestrini M.

Drugs. 2018 Nov;78(17):1791-1804. doi: 10.1007/s40265-018-0992-5.

PMID:
30390221
7.

Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.

Lattanzi S, Zaccara G, Giovannelli F, Grillo E, Nardone R, Silvestrini M, Trinka E, Brigo F.

Acta Neurol Scand. 2019 Jan;139(1):33-41. doi: 10.1111/ane.13025. Epub 2018 Sep 24.

PMID:
30194755
8.

Frequency of drug combinations between enzyme-inducing first-generation antiepileptic drugs and inducible drugs in patients with epilepsy.

Zaccara G, Gualdani E, Policardo L, Palumbo P, Francesconi P.

Epilepsy Behav. 2018 Oct;87:92-95. doi: 10.1016/j.yebeh.2018.08.004. Epub 2018 Aug 18.

PMID:
30126756
9.

Why we prefer levetiracetam over phenytoin for treatment of status epilepticus.

Zaccara G, Giorgi FS, Amantini A, Giannasi G, Campostrini R, Giovannelli F, Paganini M, Nazerian P; Tuscany study group on seizures in the emergency department and status epilepticus in adults.

Acta Neurol Scand. 2018 Jun;137(6):618-622. doi: 10.1111/ane.12928. Epub 2018 Apr 6. Review.

PMID:
29624640
10.

Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy.

Lattanzi S, Brigo F, Cagnetti C, Verrotti A, Zaccara G, Silvestrini M.

Core Evid. 2018 Mar 8;13:21-31. doi: 10.2147/CE.S142858. eCollection 2018. Review.

11.

Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis.

Lattanzi S, Brigo F, Grillo E, Cagnetti C, Verrotti A, Zaccara G, Silvestrini M.

CNS Drugs. 2018 Mar;32(3):189-196. doi: 10.1007/s40263-018-0504-x.

PMID:
29508243
12.

Efficacy of ketogenic diet for infantile spasms: A systematic review.

Prezioso G, Carlone G, Zaccara G, Verrotti A.

Acta Neurol Scand. 2018 Jan;137(1):4-11. doi: 10.1111/ane.12830. Epub 2017 Sep 6. Review.

PMID:
28875525
13.

Antiepileptic Drugs in Clinical Development: Differentiate or Die?

Zaccara G, Schmidt D.

Curr Pharm Des. 2017;23(37):5593-5605. doi: 10.2174/1381612823666170809100524. Review.

PMID:
28799516
14.

Tolerability of new antiepileptic drugs: a network meta-analysis.

Zaccara G, Giovannelli F, Giorgi FS, Franco V, Gasparini S, Benedetto U.

Eur J Clin Pharmacol. 2017 Jul;73(7):811-817. doi: 10.1007/s00228-017-2245-z. Epub 2017 Apr 4. Review.

PMID:
28378057
15.

Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies.

Zaccara G, Giovannelli F, Giorgi FS, Franco V, Gasparini S, Tacconi FM.

Br J Clin Pharmacol. 2017 Sep;83(9):1873-1879. doi: 10.1111/bcp.13296. Epub 2017 May 7. Review.

16.

Challenges in the treatment of convulsive status epilepticus.

Zaccara G, Giannasi G, Oggioni R, Rosati E, Tramacere L, Palumbo P; convulsive status epilepticus study group of the uslcentro Toscana, Italy.

Seizure. 2017 Apr;47:17-24. doi: 10.1016/j.seizure.2017.02.015. Epub 2017 Feb 28. Review.

17.

Analysis of facial expressions in parkinson's disease through video-based automatic methods.

Bandini A, Orlandi S, Escalante HJ, Giovannelli F, Cincotta M, Reyes-Garcia CA, Vanni P, Zaccara G, Manfredi C.

J Neurosci Methods. 2017 Apr 1;281:7-20. doi: 10.1016/j.jneumeth.2017.02.006. Epub 2017 Feb 20.

PMID:
28223023
18.

Identification of prevalent patients with epilepsy using administrative data: the Tuscany experience.

Bellini I, Policardo L, Zaccara G, Palumbo P, Rosati E, Torre E, Francesconi P.

Neurol Sci. 2017 Apr;38(4):571-577. doi: 10.1007/s10072-016-2798-0. Epub 2017 Jan 4.

PMID:
28054171
19.

Treatment of epilepsy in patients with Alzheimer's disease.

Giorgi FS, Guida M, Vergallo A, Bonuccelli U, Zaccara G.

Expert Rev Neurother. 2017 Mar;17(3):309-318. doi: 10.1080/14737175.2017.1243469. Epub 2016 Oct 11. Review.

PMID:
27687685
20.

Relationship between impulsivity traits and awareness of motor intention.

Giovannelli F, Mastrolorenzo B, Rossi A, Gavazzi G, Righi S, Zaccara G, Viggiano MP, Cincotta M.

Eur J Neurosci. 2016 Oct;44(7):2455-2459. doi: 10.1111/ejn.13359. Epub 2016 Aug 27.

PMID:
27521184
21.

Brivaracetam: new compound approved for the treatment of epilepsy.

Zaccara G.

Drugs Today (Barc). 2016 Apr;52(4):219-27. doi: 10.1358/dot.2016.52.4.2480987. Review.

PMID:
27252986
22.

Audio-visual integration effect in lateral occipital cortex during an object recognition task: An interference pilot study.

Giovannelli F, Giganti F, Righi S, Peru A, Borgheresi A, Zaccara G, Viggiano MP, Cincotta M.

Brain Stimul. 2016 Jul-Aug;9(4):574-6. doi: 10.1016/j.brs.2016.02.009. Epub 2016 Feb 16.

PMID:
27033011
23.

Analysis of nocebo effects of antiepileptic drugs across different conditions.

Zaccara G, Giovannelli F, Giorgi FS, Franco V, Gasparini S.

J Neurol. 2016 Jul;263(7):1274-9. doi: 10.1007/s00415-015-8018-7. Epub 2016 Jan 25. Review.

PMID:
26810717
24.

Do traditional anti-seizure drugs have a future? A review of potential anti-seizure drugs in clinical development.

Zaccara G, Schmidt D.

Pharmacol Res. 2016 Feb;104:38-48. doi: 10.1016/j.phrs.2015.12.011. Epub 2015 Dec 12. Review.

PMID:
26689774
25.

Markerless Analysis of Articulatory Movements in Patients With Parkinson's Disease.

Bandini A, Orlandi S, Giovannelli F, Felici A, Cincotta M, Clemente D, Vanni P, Zaccara G, Manfredi C.

J Voice. 2016 Nov;30(6):766.e1-766.e11. doi: 10.1016/j.jvoice.2015.10.014. Epub 2015 Nov 29.

PMID:
26620259
26.

The adverse event profile of levetiracetam: A meta-analysis on children and adults.

Verrotti A, Prezioso G, Di Sabatino F, Franco V, Chiarelli F, Zaccara G.

Seizure. 2015 Sep;31:49-55. doi: 10.1016/j.seizure.2015.07.004. Epub 2015 Jul 14.

27.

Foetal safety of old and new antiepileptic drugs.

Verrotti A, Mencaroni E, Castagnino M, Zaccara G.

Expert Opin Drug Saf. 2015 Oct;14(10):1563-71. doi: 10.1517/14740338.2015.1084288. Epub 2015 Sep 2. Review.

PMID:
26329145
28.

No effects of 20 Hz-rTMS of the primary motor cortex in vegetative state: A randomised, sham-controlled study.

Cincotta M, Giovannelli F, Chiaramonti R, Bianco G, Godone M, Battista D, Cardinali C, Borgheresi A, Sighinolfi A, D'Avanzo AM, Breschi M, Dine Y, Lino M, Zaccara G, Viggiano MP, Rossi S.

Cortex. 2015 Oct;71:368-76. doi: 10.1016/j.cortex.2015.07.027. Epub 2015 Aug 4.

PMID:
26301875
29.

A Meta-analysis of the Cortical Silent Period in Epilepsies.

Cincotta M, Giovannelli F, Borgheresi A, Tramacere L, Viggiano MP, Zaccara G.

Brain Stimul. 2015 Jul-Aug;8(4):693-701. doi: 10.1016/j.brs.2015.04.008. Epub 2015 Apr 24. Review.

PMID:
25981158
30.

Clinical utility of eslicarbazepine: current evidence.

Zaccara G, Giovannelli F, Cincotta M, Carelli A, Verrotti A.

Drug Des Devel Ther. 2015 Feb 10;9:781-9. doi: 10.2147/DDDT.S57409. eCollection 2015. Review.

31.

Placebo and nocebo responses in drug trials of epilepsy.

Zaccara G, Giovannelli F, Schmidt D.

Epilepsy Behav. 2015 Feb;43:128-34. doi: 10.1016/j.yebeh.2014.12.004. Epub 2015 Feb 19. Review.

PMID:
25703333
32.

Safety and efficacy of diazepam autoinjector for the management of epilepsy.

Verrotti A, Milioni M, Zaccara G.

Expert Rev Neurother. 2015 Feb;15(2):127-33. doi: 10.1586/14737175.2015.1003043. Review.

PMID:
25614951
33.

Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs.

Zaccara G, Perucca E.

Epileptic Disord. 2014 Dec;16(4):409-31. doi: 10.1684/epd.2014.0714. Review.

34.

"Thirty-day neurologic improvement associated with early versus delayed carotid endarterectomy in symptomatic patients".

Chisci E, Pigozzi C, Troisi N, Tramacere L, Zaccara G, Cincotta M, Ercolini L, Michelagnoli S.

Ann Vasc Surg. 2015 Apr;29(3):435-42. doi: 10.1016/j.avsg.2014.08.028. Epub 2014 Nov 22.

PMID:
25463336
35.

The treatment of neonatal seizures: focus on Levetiracetam.

Loiacono G, Masci M, Zaccara G, Verrotti A.

J Matern Fetal Neonatal Med. 2016;29(1):69-74. doi: 10.3109/14767058.2014.986651. Epub 2014 Dec 5. Review.

PMID:
25385270
36.

Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies.

Giovannelli F, Zaccara G, Cincotta M, Loiacono G, Verrotti A.

J Neurol. 2015 Jun;262(6):1401-6. doi: 10.1007/s00415-014-7535-0. Epub 2014 Oct 14. Review.

PMID:
25311571
37.

Adverse events, placebo and nocebo effects in placebo-treated paediatric patients with refractory focal epilepsies. Analysis of double-blind studies.

Zaccara G, Giovannelli F, Franco V, Cincotta M, Tramacere L, Verrotti A.

Epilepsy Res. 2014 Dec;108(10):1685-93. doi: 10.1016/j.eplepsyres.2014.09.015. Epub 2014 Sep 22. Review.

PMID:
25288026
38.

"…The times they aren't a-changin'…" rTMS does not affect basic mechanisms of temporal discrimination: a pilot study with ERPs.

Giovannelli F, Ragazzoni A, Battista D, Tarantino V, Del Sordo E, Marzi T, Zaccara G, Avanzini G, Viggiano MP, Cincotta M.

Neuroscience. 2014 Oct 10;278:302-12. doi: 10.1016/j.neuroscience.2014.08.024. Epub 2014 Aug 26.

PMID:
25168726
39.

Adverse events of placebo-treated, drug-resistant, focal epileptic patients in randomized controlled trials: a systematic review.

Zaccara G, Giovannelli F, Cincotta M, Loiacono G, Verrotti A.

J Neurol. 2015 Mar;262(3):501-15. doi: 10.1007/s00415-014-7391-y. Epub 2014 Jun 11. Review.

PMID:
24916828
40.

Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.

Zaccara G, Almas M, Pitman V, Knapp L, Posner H.

Epilepsia. 2014 Jul;55(7):1048-57. doi: 10.1111/epi.12679. Epub 2014 Jun 5.

41.

Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective.

Zaccara G, Giovannelli F, Bell GS, Sander JW.

Eur J Clin Pharmacol. 2014 Jun;70(6):647-54. doi: 10.1007/s00228-014-1669-y. Epub 2014 Mar 28.

PMID:
24676410
42.

Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): a pragmatic randomised trial.

Beretta S, Beghi E, Messina P, Gerardi F, Pescini F, La Licata A, Specchio L, Ferrara M, Canevini MP, Turner K, La Briola F, Franceschetti S, Binelli S, Giglioli I, Galimberti CA, Fattore C, Zaccara G, Tramacere L, Sasanelli F, Pirovano M, Ferrarese C.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):889-94. doi: 10.1136/jnnp-2013-306553. Epub 2014 Jan 8.

PMID:
24403284
43.

Eslicarbazepine acetate: an update on efficacy and safety in epilepsy.

Verrotti A, Loiacono G, Rossi A, Zaccara G.

Epilepsy Res. 2014 Jan;108(1):1-10. doi: 10.1016/j.eplepsyres.2013.10.005. Epub 2013 Oct 23. Review.

PMID:
24225327
44.

Withdrawal of antiepileptic drugs: guidelines of the Italian League Against Epilepsy.

Beghi E, Giussani G, Grosso S, Iudice A, La Neve A, Pisani F, Specchio LM, Verrotti A, Capovilla G, Michelucci R, Zaccara G.

Epilepsia. 2013 Oct;54 Suppl 7:2-12. doi: 10.1111/epi.12305. Review.

45.

The adverse event profile of zonisamide: a meta-analysis.

Verrotti A, Loiacono G, Di Sabatino F, Zaccara G.

Acta Neurol Scand. 2013 Nov;128(5):297-304. doi: 10.1111/ane.12147. Epub 2013 Jun 13. Review.

PMID:
23763367
46.

AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel.

Zaccara G, Giovannelli F, Cincotta M, Iudice A.

Expert Rev Neurother. 2013 Jun;13(6):647-55. doi: 10.1586/ern.13.46. Review.

PMID:
23739002
47.

Network meta-analysis and the comparison of efficacy and tolerability of anti-epileptic drugs for treatment of refractory focal epilepsy.

Zaccara G, Sisodiya SM, Giovannelli F, Walker MC, Heaney DC, Angus-Leppan H, Wehner T, Eriksson SH, Liu R, Rugg-Gunn F, Shorvon SD, Sander JW.

Br J Clin Pharmacol. 2013 Nov;76(5):827-8. doi: 10.1111/bcp.12175. No abstract available.

48.

Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.

Zaccara G, Giovannelli F, Maratea D, Fadda V, Verrotti A.

Seizure. 2013 Sep;22(7):528-36. doi: 10.1016/j.seizure.2013.03.016. Epub 2013 Apr 25. Review.

49.

The adverse event profile of perampanel: meta-analysis of randomized controlled trials.

Zaccara G, Giovannelli F, Cincotta M, Verrotti A, Grillo E.

Eur J Neurol. 2013 Aug;20(8):1204-11. doi: 10.1111/ene.12170. Epub 2013 Apr 23. Review.

PMID:
23607817
50.

Novel treatment options for epilepsy: focus on perampanel.

Franco V, Crema F, Iudice A, Zaccara G, Grillo E.

Pharmacol Res. 2013 Apr;70(1):35-40. doi: 10.1016/j.phrs.2012.12.006. Epub 2013 Jan 1. Review.

PMID:
23287426

Supplemental Content

Loading ...
Support Center